You are here

  • Home
  • Archive
  • Volume 84, Issue 5
  • Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?

Article Text

Article menu
Download PDFPDF
Scientific correspondence
Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?
  1. Cristiano Giustia,
  2. Riccardo Schiaffinib,
  3. Daniela Boscob,
  4. Paolo Ciampalinib,
  5. Antonio Pantaleob,
  6. Enzo M Vingoloa,
  7. Patrizia Gargiulob
  1. aUniversity “La Sapienza”, Rome, Italy, bInstitute of Internal Medicine II
  1. Cristiano Giusti, MD, Via Cassia 1280 (Pal B1, int 10), I-00189 Rome, Italy crigiust{at}tin.it

Abstract

AIMS To investigate whether lupus anticoagulant (LA) positivity, a marker of endothelial dysfunction, might be relevant to the pathogenesis of diabetic retinopathy (DR).

METHODS 32 IDDM patients were examined for LA, fibrinogen, prothrombin (PT), PTT, prothrombin degradation products (F1+2), and activated protein C (APC).

RESULTS APC decreased and F1+2 increased significantly in LA positive but not in LA negative patients; 60% of LA positive and 18% of LA negative subjects had DR. PT, PTT, and fibrinogen levels were insignificant.

CONCLUSION These preliminary findings suggest that LA positivity could represent an additional risk factor for DR, acting as a link between the immunological and haemostatic systems.

  • lupus anticoagulant positivity
  • insulin dependent diabetes

https://doi.org/10.1136/bjo.84.5.531

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes